anne pariser of the fda on natural history studies in rare disease at world orphan drug congress usa
Published 11 years ago • 464 plays • Length 25:56Download video MP4
Download video MP3
Similar videos
-
19:50
enobia & lapidusdata on history and epidemiology in rare disease at world orphan drug congress usa
-
5:50
dr. anne pariser closing presentation at the us conference on rare diseases and orphan products
-
26:58
andrew callos of pfizer on sustainable business in rare disease at world orphan drug congress usa
-
24:14
yann le cam of eurordis on eu rare disease treatment at world orphan drug congress usa
-
39:28
exploring lost herbal remedies
-
57:24
natural history studies for rare diseases
-
7:55
phelan-mcdermid syndrome foundation patient testimony at world orphan drug congress usa
-
4:08
john crowley of amicus therapeutics at world orphan drug congress usa
-
4:58
dr anne pariser provides an overview nih’s office of rare diseases research
-
5:42
david lee of health canada on fast tracking orphan drugs at world orphan drug congress usa
-
12:25
world orphan drug congress (2019)
-
37:32
panel session on global patient registry status updates at world orphan drug congress usa 2013
-
3:03
anne r. pariser, md discusses rare disease research at the nih
-
2:56
orphan drugs, exclusivity, and suing the fda
-
28:25
angus russell of shire on social responsibility in rare diseases at world orphan drug congress usa
-
5:37
world orphan drug congress 2014
-
8:00
orphan drug congress april 2013: part 2, regulatory landscape
-
18:32
introduction to fda office of orphan product development and rare diseases
-
3:26
orphacodes for rare diseases
-
7:40
orphan drugs conquering rare diseases one-by-one
-
55:50
meet the authors: orphan drug development for rare diseases